Or Refractory Mature Lymphoid Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-10-01
Clinical Trial Update: A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid Neoplasms [Phase 1]
Phase 1 trial update showing SHR2554 is being studied in relapsed or refractory mature lymphoid neoplasms; the study (NCT03603951) is active…